Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07205367 · ClinicalTrials.gov registry record · NA

Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II

A NA study of Cardiac Arrhythmia, sponsored by iRhythm Technologies.

Active
Registry status
NA
Development phase
150
Enrollment target
2
Study locations

NCT07205367 is a NA study of Cardiac Arrhythmia that is active but no longer recruiting, run by iRhythm Technologies. The registered enrollment target is 150 participants, below the 201-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (25% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07205367, a NA study of Cardiac Arrhythmia, is active but no longer recruiting, sponsored by iRhythm Technologies.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
2
Study locations

Study Summary

This trial assesses the wear performance of the Zio monitor, a long-term continuous ambulatory patch ECG monitor, in a representative population by evaluating (1) the wear duration (up to 30 days) of the device, (2) the percentage of analyzable electrocardiographic time and (3) safety by reviewing all adverse events.

Conditions Studied

Interventions

  • DEVICE Zio Monitor

Study Locations (2)

California

  • iRhythm Technologies - San Francisco, CA - San Francisco

Illinois

  • iRhythm Technologies - Deerfield, IL - Deerfield

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-01-06
Est. Completion 2025-10-31
Phase NA

Sponsor

iRhythm Technologies

4 total trials

What the Registry Record Tells You About NCT07205367

The ClinicalTrials.gov registry entry for NCT07205367 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 201-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (25% lower). The listed sponsor is iRhythm Technologies, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiac Arrhythmia appearing as the primary indexed condition, and to 1 intervention - of which Zio Monitor is the first listed.

NCT07205367 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Illinois.

Frequently Asked Questions

What is clinical trial NCT07205367 about?

NCT07205367 is a clinical study titled "Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II". This trial assesses the wear performance of the Zio monitor, a long-term continuous ambulatory patch ECG monitor, in a representative population by evaluating (1) the wear duration (up to 30 days) of the device, (2) the percentage of analyzable electrocardiographic time and (3) safety by reviewing a...

What is the current status of trial NCT07205367?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-01-06. Estimated completion is 2025-10-31.

What conditions does trial NCT07205367 study?

This clinical trial studies the following conditions: Cardiac Arrhythmia.

What interventions are being tested in trial NCT07205367?

The interventions under investigation include: Zio Monitor (DEVICE).

Who is sponsoring clinical trial NCT07205367?

This trial is sponsored by iRhythm Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07205367 being conducted?

This trial has 2 study locations across California, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiac Arrhythmia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.